HomeELAN • NYSE
add
Elanco Animal Health Inc
Previous close
$12.84
Day range
$12.71 - $13.19
Year range
$8.52 - $18.80
Market cap
6.41B USD
Avg Volume
4.75M
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 1.18B | 12.02% |
Operating expense | 574.00M | 0.70% |
Net income | -50.00M | 48.45% |
Net profit margin | -4.22 | 54.03% |
Earnings per share | 0.30 | 66.67% |
EBITDA | 277.00M | 20.43% |
Effective tax rate | -56.25% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 416.00M | 2.21% |
Total assets | 13.76B | -12.86% |
Total liabilities | 7.82B | -6.61% |
Total equity | 5.94B | — |
Shares outstanding | 494.33M | — |
Price to book | 1.07 | — |
Return on assets | 2.07% | — |
Return on capital | 2.45% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -50.00M | 48.45% |
Cash from operations | 200.00M | 227.87% |
Cash from investing | -33.00M | 23.26% |
Cash from financing | -93.00M | -338.46% |
Net change in cash | 71.00M | 44.90% |
Free cash flow | 232.25M | 58.13% |
About
Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world. Wikipedia
Founded
1954
Website
Employees
9,550